공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 말초혈관용 기기 시장 : 예측(2021-2026년)

Global Peripheral Vascular Devices Market - Forecasts from 2021 to 2026

리서치사 Knowledge Sourcing Intelligence
발행일 2021년 10월 상품 코드 1023189
페이지 정보 영문 112 Pages
가격
US $ 3,950 ₩ 4,730,000 PDF (Single User License)
US $ 4,550 ₩ 5,448,000 PDF (Multiple User License)
US $ 6,950 ₩ 8,322,000 PDF (Enterprise License)


세계의 말초혈관용 기기 시장 : 예측(2021-2026년) Global Peripheral Vascular Devices Market - Forecasts from 2021 to 2026
발행일 : 2021년 10월 페이지 정보 : 영문 112 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 말초혈관용 기기 시장 규모는 2019년의 49억 8,800만 달러에서 2026년에는 68억 4,900만 달러를 기록할 것으로 보여지며, 예측 기간 동안 4.63%의 CAGR로 추이 할 것으로 예상 됩니다.

말초 혈관 질환(PVD)은 장기와 팔다리 및 머리에 혈액을 운반하는 동맥에 죽상 경화 플라크가 형성됨에 따라 발병합니다. 말초 동맥 폐색 질환(PAOD), 말초 동맥 질환(PAD), 말초폐색성 동맥경화증이라고도합니다.

말초 혈관 질환은 말초 혈관 및 말초 동맥 모두에 관련된 질환으로, 신체의 말초 및 심장 순환에 미치는 영향을 미칩니다. 유치 동맥 카테터의 경로, 혈관 카테터 EVAR 스텐트 접합부, 혈행 역학적으로 흐름을 바꾸는 장치, 플라크를 적정화하는 장치 등 말초혈관용 기기는 말초 혈관과 관상 동맥의 감염을 치료하기 위해 이용되어지며, 말초 혈관 내 치료와 관상 동맥 치료 기법에 사용됩니다. 이러한 장치는 수술 중 환자에게 발생하는 문제를 최소화하는데 사용됩니다.

세계의 말초혈관용 기기(Peripheral Vascular Devices) 시장을 조사했으며, 시장 개요/시장 성장 요인 및 저해 요인/기업 간 경쟁 관계/종류별·최종 사용자별·지역별 시장 분석 등을 제공합니다 .

목차

제1장 서론

  • 시장 정의
  • 시장 세분화

제2장 조사 방법

  • 조사 데이터
  • 전제 조건

제3장 개요

  • 조사의 하이라이트

제4장 시장 역학

  • 시장의 추진력
  • 시장 저해 요인
  • 포터의 5세력 모형
    • 공급 기업의 경쟁력
    • 구매자의 경쟁력
    • 신규 진입 업체의 위협
    • 대체품의 위협
    • 기능의 경쟁 기업 간의 경쟁 관계
  • 기능 가치 사슬 분석

제5장 종류별 : 말초혈관용 기기 시장 분석

  • 서론
  • 말초 혈관 스텐트
  • 경피적 혈관 성형술(PTA) 풍선 카테터
  • 경피적 혈관 성형술(PTA) 가이드 와이어
  • 색전 보호 장치
  • 기타

제6장 최종 사용자별 : 말초혈관용 기기 시장 분석

  • 서론
  • 병원 및 진료소
  • 외래 수술 센터

제7장 지역별 : 말초혈관용 기기 시장 분석

  • 서론
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 남미
    • 브라질
    • 아르헨티나
    • 기타
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 기타
  • 중동과 아프리카
    • 이스라엘
    • 사우디아라비아
    • 기타
  • 아시아 태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
    • 대만
    • 태국
    • 인도네시아
    • 기타

제8장 경쟁 환경 분석

  • 주요 기업과 전략 분석
  • 신생 기업과 시장의 수익성
  • 합병, 인수, 합의, 공동 연구
  • 업체의 경쟁력 매트릭스

제9장 기업 개요

  • Medtronic
  • Terumo
  • Abbott
  • Cordis
  • Biomerics
  • Cardiva Medical, Inc.
  • Vasorum Ltd
  • Biotronik GMBH&CO.KG
  • Boston Scientific Corporation
  • TZ Medical, Inc
LYJ 21.09.07

The global peripheral vascular devices market is projected to grow at a CAGR of 4.63% to reach US$6.849 billion by 2026, from US$4.988 billion in 2019.

Medical devices used to treat peripheral vascular disease are known as peripheral vascular devices (PVD). PVD is characterized by plaque accumulation, which results in artery constriction or blockage and inadequate blood flow. Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloon Catheters, Peripheral Transluminal Angioplasty (PTA) Guidewires, Embolic Protection Devices are some of the devices used to treat PVD. Surgical or minimally invasive catheter-based methods can be used to treat peripheral vascular devices. Over the next few years, the peripheral vascular devices market is projected to be driven by rapid growth in the elderly population and an increase in the incidence of peripheral vascular disorders. In addition, the rising incidence of diabetes and increased demand for Minimally Invasive Endovascular treatments are expected to propel the market forward in the approaching years. Furthermore, rising diabetes occurrences and the approval of new and improved medicines are expected to propel the market forward throughout the anticipated period.

One of the primary causes driving demand for peripheral vascular devices is the increasing rise of the senior population, which is at a higher risk of acquiring peripheral vascular illnesses such as atherosclerosis and aneurysms. This is because, as people become older, hereditary and lifestyle factors can cause plaque to build up in the arteries. According to research published by the US National Library of Medicine, more than 202 million individuals worldwide suffer from peripheral vascular disease, with more than two-thirds of them living in low- and middle-income nations. The incidence of peripheral vascular disorders is projected to rise further in the coming years due to the rising elderly population in all major areas throughout the world. As a result, throughout the projection period, demand and acceptance of peripheral vascular devices will grow in key markets.

The most profitable market for peripheral vascular devices is expected to be the North America and Asia-Pacific region. The availability of a huge patient pool with unmet medical requirements is one of the major reasons contributing to this region's quickest development. Furthermore, the peripheral vascular devices market is anticipated to increase as the healthcare environment in Asian nations improves, along with GDP growth and government efforts. Furthermore, the rising incidence of peripheral vascular illnesses linked to obesity, diabetes, and hypertension, as well as the growing elderly population, need for less invasive treatment alternatives, and the prevalence of disease-causing lifestyles, are all important contributors boosting the market growth in the region.

Growth Factors

Growth opportunities in emerging economies to propel the market growth

One of the major reasons for the growth of the global peripheral vascular devices market is growing growth opportunities in emerging economies owing to less rigorous regulatory rules and minimal competition, emerging markets like as China, India, Singapore, and Brazil are projected to develop rapidly in the future years. The growing population among these countries and the high prevalence of peripheral diseases are further fueling the market growth for global peripheral vascular devices. Medical device demand in emerging nations is rising at a faster rate than in industrialized ones. Due to the growth of the private healthcare sector to meet the requirements of the growing middle-class population and rising disposable incomes, the medical equipment business in emerging nations is quickly growing.

COVID-19 Impact

The COVID-19 pandemic has had a great impact on the world as a whole and has led to economic breakdown and loss of life. Patient visits to hospitals have decreased considerably as a result of the lockdown in several nations. As a result, there are fewer diagnostic tests available. This has resulted in a further drop in sales of peripheral vascular devices. Elective operations have been postponed in a majority of nations throughout the world to avoid the spread of COVID-19. Many peripheral vascular interventional treatments have been postponed due to the fact that the bulk of these operations are elective which is obstructing the growth of the peripheral vascular devices market is the course of the pandemic. Supply lines were also affected by shuttered production sites owing to lockdowns, and clinical trial recruitment was down.

Competitive Insights

The market leaders for the pretreatment coating market are Medtronic, Terumo, Abbott, Cordis, Biomerics, Cardiva Medical Inc., Vasorum Ltd., Biotronik GMBH & CO.KG, Boston Scientific Corporation, and TZ Medical Inc.

Segmentation:

By Type

  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
  • Peripheral Transluminal Angioplasty (PTA) Guidewires
  • Embolic Protection Devices
  • Others

By End-Users

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Taiwan
    • Thailand
    • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Peripheral Vascular Devices Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Peripheral Vascular Stents
  • 5.3. Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
  • 5.4. Peripheral Transluminal Angioplasty (PTA) Guidewires
  • 5.5. Embolic Protection Devices
  • 5.6. Others

6. Peripheral Vascular Devices Market Analysis, By End-User

  • 6.1. Introduction
  • 6.2. Hospitals & Clinics
  • 6.3. Ambulatory Surgical Centers

7. Peripheral Vascular Devices Market Analysis, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. UK
    • 7.4.2. France
    • 7.4.3. Germany
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Thailand
    • 7.6.6. Taiwan
    • 7.6.7. Indonesia
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. Medtronic
  • 9.2. Terumo
  • 9.3. Abbott
  • 9.4. Cordis
  • 9.5. Biomerics
  • 9.6. Cardiva Medical Inc.
  • 9.7. Vasorum Ltd.
  • 9.8. Biotronik GMBH & CO.KG
  • 9.9. Boston Scientific Corporation
  • 9.10. TZ Medical Inc.
Back to Top
전화 문의
F A Q